Bulevirtide is a potent antiviral peptide used in the biomedical industry. It exhibits strong inhibitory activity against hepatitis delta virus (HDV), a severe co-infection with hepatitis B virus (HBV) that causes chronic liver disease.
CAT No: R2015
CAS No:2012558-47-1
Synonyms/Alias:Bulevirtide;Bulevirtide (INN);Bulevirtide [INN];2012558-47-1;bulevirtidum;Bulevirtida;Hepcludextm;Hepcludex;Hepcludex (TN);formerly Myrcludex B;MYRCLUDEX;Bulevirtide [USAN];WKM56H3TLB;BULEVIRTIDE [WHO-DD];915207G;N-TETRADECANOYLGLYCYL-THR-ASN-LEU-SER-VAL-PRO-ASN-PRO-LEU-GLY-PHE-PHE-PRO-ASP-HIS-GLN-LEU-ASP-PRO-ALA-PHE-GLY-ALA-ASN-SER-ASN-ASN-PRO-ASP-TRP-ASP-PHE-ASN-PRO-ASN-LYS-ASP-HIS-TRP-PRO-GLU-ALA-ASN-LYS-VAL-GLY-NH2;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.